Valuation: CellaVision AB

Market Cap 3.34B 344M 302M 281M 258M 485M 33.15B 492M 1.3B 16.3B 1.29B 1.26B 56.36B P/E 2026 *
24x
P/E 2027 * 18.8x
Enterprise Value 3.15B 325M 285M 265M 244M 458M 31.29B 465M 1.23B 15.38B 1.22B 1.19B 53.19B EV / Sales 2026 *
4.07x
EV / Sales 2027 * 3.56x
Free-Float
83.08%
Yield 2026 *
1.96%
Yield 2027 * 2.3%
1 day-0.36%
1 week-4.89%
Current month+2.79%
1 month+2.34%
3 months+16.47%
6 months-8.97%
Current year-10.94%
1 week 138.4
Extreme 138.4
152.6
1 month 131.8
Extreme 131.8
153
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 60 2022-05-10
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
6/12/26 Buy 760 0.0032%
6/9/26 Buy

Director

314 0.0013%
6/9/26 Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%-4.89%-21.61%-39.26% 339M
-0.36%-9.20%+14.18%-38.41% 15.63B
-7.90%-1.58%+0.67%+98.26% 1.79B
-2.53%-6.96%-38.59%-81.69% 1.13B
-1.41%-4.66%-38.14%+11.27% 960M
-3.39%-9.44%-31.96%-55.49% 630M
-2.46%-12.40%-49.22%-57.99% 517M
+2.43%+4.08%+45.43%-52.57% 452M
+1.52%-3.98%-57.01%-61.54% 359M
-4.04%-6.39%+50.88% - 325M
Average -2.07%-3.96%-12.54%-30.82% 2.21B
Weighted average by Cap. -1.73%-7.99%+4.80%-28.91%

Financials

2026 *2027 *
Net sales 774M 79.81M 70.1M 65.19M 59.82M 112M 7.69B 114M 302M 3.78B 300M 293M 13.06B 870M 89.65M 78.74M 73.23M 67.19M 126M 8.63B 128M 340M 4.24B 337M 329M 14.68B
Net income 139M 14.33M 12.59M 11.71M 10.74M 20.18M 1.38B 20.5M 54.31M 679M 53.81M 52.65M 2.35B 178M 18.34M 16.11M 14.98M 13.75M 25.83M 1.77B 26.23M 69.51M 868M 68.86M 67.37M 3B
Net Debt -188M -19.33M -16.98M -15.79M -14.49M -27.22M -1.86B -27.64M -73.26M -915M -72.57M -71.01M -3.16B -242M -24.98M -21.94M -20.4M -18.72M -35.18M -2.41B -35.72M -94.65M -1.18B -93.77M -91.75M -4.09B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-07-24 SEK 140.00 +0.72% 14,466
26-07-23 SEK 139.00 -2.25% 13,113
26-07-22 SEK 142.20 -1.80% 16,130
26-07-21 SEK 144.80 -2.69% 23,266
26-07-20 SEK 148.80 +1.09% 29,950
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
139.00SEK
Average target price
176.75SEK
Spread / Average Target
+27.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock